Udder Health Market Size, Share & Trends by Product (Pharmaceuticals (Antibiotics, Intramammary Infusions), Devices (Milk Quality Analysers), Supplements)), Veterinary Care Settings (Dairy Farms, Veterinary Hospitals & Clinics), Animal Type - Global Forecast to 2029
The global udder health market is projected to reach USD 1.6 billion by 2029 from USD 1.2 billion in 2024 at a CAGR of 5.9%. The competitive landscape includes the analysis of the key growth strategies adopted by major players between January 2020 and May 2024. Players in the global udder health market have employed various strategies to expand their global footprint and increase their market shares such as agreements, divestitures, expansions, and acquisitions.
“The Devices segment accounted the second-largest market share in the udder health market.”
In the udder health market, the Devices segment holds the second-largest share because of the growing use of equipment like teat sprayers, teat dip applicators, milk quality analyzers, and mastitis detectors. These devices play a crucial role in maintaining the health of dairy cow udders by preventing infections and ensuring milk quality. Farmers increasingly adopt these tools to improve dairy production efficiency and animal welfare standards. The rise in demand is fueled by advancements in technology that enhance the accuracy and effectiveness of these devices, making them indispensable in modern dairy farm operations.
“Dairy farms segment of the udder health market is expected to witness the fastest CAGR.”
By veterinary care setting type, the dairy farms segment has witnessed the fastest growth rate in the udder health market. This is largely because small and medium-scale dairy farms are gradually switching from manual milking to mechanized milking systems. This transition helps improve udder health by reducing the risk of infections like mastitis, ensuring more consistent and hygienic milking processes. As a result, these farms are better able to produce high-quality milk, which drives the segment's rapid growth.
“The Dairy cattle segment of the udder health market accounted for the largest market share.”
Based on animal type, the dairy cattle segment accounted for the largest market share in the udder health market because of growing demand for milk and milk products. Dairy cattles are crucial for milk production, making their udder health vital for consistent supply. Farmers focus on keeping their cows healthy to ensure high-quality milk production, which drives the market for udder health products and services. This segment's dominance reflects the industry's emphasis on maintaining cow health to meet the rising global demand for milk and dairy products.
“Clinical mastitis segment of the udder health market is expected to witness the fastest CAGR.”
By disease type, the clinical mastitis has experienced the fastest CAGR, in the udder health market, due to rising cases of mastitis and other related issue. The increasing prevalence of this disease has driven demand for effective treatments and management solutions within the market. As dairy farms strive to maintain herd health and productivity, there's a growing emphasis on products and practices that can prevent and treat mastitis effectively, contributing to the segment's rapid growth in the udder health industry.
“North America to have the second largest market share in the udder health market during the forecast period.”
North America holds the second largest share in the udder health market. This is mainly because farmers in this region have higher incomes, allowing them to invest more in the health and care of their dairy cows. As their earnings grow, they can afford better products and services to maintain the udder health of their livestock. This increase in spending power boosts the market, making North America a significant player in this sector.
A breakdown of the primary participants (supply side) for the udder health market referred to for this report is provided below:
The prominent players in the udder health market include Vetoquinol S.A. (France), Zoetis Inc. (US), Merck & Co., Inc. (US), Virbac (France), Ecolab (US), Boehringer Ingelheim GmbH (Germany), Elanco Animal Health Incorporated (US), DeLaval (Sweden), Orffa (Netherlands), AHV International (Netherlands), Boumatic LLC (US), GEA Group Aktiengesellschaft (Germany), G Shepherd Animal Health (UK), Ceva Sante Animale (France), Albert Kerbl GmbH (Germany), Ambic Equipment Limited (England), Lely (Netherlands), Zenex Animal Health India Private Limited (India), Draminski S.A. (Poland), Ring Biotechnology Co Ltd. (China), Nicosia Biolabs International Private Limited (India), Blackmango Herb (India), Koru Diagnostics Ltd. (New Zealand), Mastaplex (New Zealand), and AR Brown Co., Ltd. (Japan).
Research Coverage:
The market analysis examines the udder health market in numerous segments. It seeks to estimate the market size and growth potential across many segments, including product, veterinary care setting, animal type, disease type and geography. The study also includes a detailed competitive analysis of the market's top competitors, as well as company profiles, significant insights about their product and business offerings, recent developments, and key market strategies.
Key Benefits of Buying the Report:
The study will assist industry leaders/new entrants in this market by providing information on the closest approximations of the udder health market and its segments. This research will assist stakeholders understand the competitive landscape, obtaining insights to better position their firms, and developing appropriate go-to-market strategies. The study will also assist stakeholders in understanding the market pulse and obtaining information on major market drivers, constraints, opportunities, and challenges.
This report provides insights into the following pointers:
“The Devices segment accounted the second-largest market share in the udder health market.”
In the udder health market, the Devices segment holds the second-largest share because of the growing use of equipment like teat sprayers, teat dip applicators, milk quality analyzers, and mastitis detectors. These devices play a crucial role in maintaining the health of dairy cow udders by preventing infections and ensuring milk quality. Farmers increasingly adopt these tools to improve dairy production efficiency and animal welfare standards. The rise in demand is fueled by advancements in technology that enhance the accuracy and effectiveness of these devices, making them indispensable in modern dairy farm operations.
“Dairy farms segment of the udder health market is expected to witness the fastest CAGR.”
By veterinary care setting type, the dairy farms segment has witnessed the fastest growth rate in the udder health market. This is largely because small and medium-scale dairy farms are gradually switching from manual milking to mechanized milking systems. This transition helps improve udder health by reducing the risk of infections like mastitis, ensuring more consistent and hygienic milking processes. As a result, these farms are better able to produce high-quality milk, which drives the segment's rapid growth.
“The Dairy cattle segment of the udder health market accounted for the largest market share.”
Based on animal type, the dairy cattle segment accounted for the largest market share in the udder health market because of growing demand for milk and milk products. Dairy cattles are crucial for milk production, making their udder health vital for consistent supply. Farmers focus on keeping their cows healthy to ensure high-quality milk production, which drives the market for udder health products and services. This segment's dominance reflects the industry's emphasis on maintaining cow health to meet the rising global demand for milk and dairy products.
“Clinical mastitis segment of the udder health market is expected to witness the fastest CAGR.”
By disease type, the clinical mastitis has experienced the fastest CAGR, in the udder health market, due to rising cases of mastitis and other related issue. The increasing prevalence of this disease has driven demand for effective treatments and management solutions within the market. As dairy farms strive to maintain herd health and productivity, there's a growing emphasis on products and practices that can prevent and treat mastitis effectively, contributing to the segment's rapid growth in the udder health industry.
“North America to have the second largest market share in the udder health market during the forecast period.”
North America holds the second largest share in the udder health market. This is mainly because farmers in this region have higher incomes, allowing them to invest more in the health and care of their dairy cows. As their earnings grow, they can afford better products and services to maintain the udder health of their livestock. This increase in spending power boosts the market, making North America a significant player in this sector.
A breakdown of the primary participants (supply side) for the udder health market referred to for this report is provided below:
- By Company Type: Tier 1–35%, Tier 2–25%, and Tier 3–40%
- By Designation: C-level–45%, Director Level–25%, and Others–30%
- By Region: North America–36%, Europe–26%, Asia Pacific–21%, Latin America-10%, and Middle East & Africa_ 7%
- By Veterinary Care Setting Type: Dairy Farms-65%, Veterinary Hospitals and Clinics-35%
- By Designation: Farm Owners-55%, Veterinarians-45%
- By Region: North America–34%, Europe–27%, Asia Pacific–23%, Latin America-9%, and Middle East & Africa-7%
The prominent players in the udder health market include Vetoquinol S.A. (France), Zoetis Inc. (US), Merck & Co., Inc. (US), Virbac (France), Ecolab (US), Boehringer Ingelheim GmbH (Germany), Elanco Animal Health Incorporated (US), DeLaval (Sweden), Orffa (Netherlands), AHV International (Netherlands), Boumatic LLC (US), GEA Group Aktiengesellschaft (Germany), G Shepherd Animal Health (UK), Ceva Sante Animale (France), Albert Kerbl GmbH (Germany), Ambic Equipment Limited (England), Lely (Netherlands), Zenex Animal Health India Private Limited (India), Draminski S.A. (Poland), Ring Biotechnology Co Ltd. (China), Nicosia Biolabs International Private Limited (India), Blackmango Herb (India), Koru Diagnostics Ltd. (New Zealand), Mastaplex (New Zealand), and AR Brown Co., Ltd. (Japan).
Research Coverage:
The market analysis examines the udder health market in numerous segments. It seeks to estimate the market size and growth potential across many segments, including product, veterinary care setting, animal type, disease type and geography. The study also includes a detailed competitive analysis of the market's top competitors, as well as company profiles, significant insights about their product and business offerings, recent developments, and key market strategies.
Key Benefits of Buying the Report:
The study will assist industry leaders/new entrants in this market by providing information on the closest approximations of the udder health market and its segments. This research will assist stakeholders understand the competitive landscape, obtaining insights to better position their firms, and developing appropriate go-to-market strategies. The study will also assist stakeholders in understanding the market pulse and obtaining information on major market drivers, constraints, opportunities, and challenges.
This report provides insights into the following pointers:
- Analysis of key Drivers: Drivers (Increasing Demand of Milk and Dairy Products, Increasing number of veterinary practitioner in developed economies, Increasing Incidence of Mastitis and Other Udder Health Disorders, Technological Advancements in Udder Health Monitoring), Restrains (Lack of Awareness and Education Among Small-Scale Dairy Farmers), Opportunities (Gradual transitions of small and medium-scale dairy farms from manual milking to mechanized milking solutions, Increasing per capita income of farmers in developing countries), Challenges (Regulatory control on livestock industry to reduce outbreak of diseases) influencing the growth of the udder health market.
- Market Penetration: Comprehensive information on the product portfolios of the leading companies in the udder health market. The report breaks down the market by product type, veterinary care setting types, animal types, disease types and region.
- Product Enhancement/Innovation: Detailed information about forthcoming trends and product launches in the udder health market.
- Market Development: Comprehensive data on attractive rising markets broken down by product category, veterinary care setting types, animal types, disease types and region.
- Market Diversification: Comprehensive information on new products, expanding geographies, current advancements, and investments in the udder health market.
- Competitive Assessment: In-depth analysis of market share, growth strategies, product and service offerings, and capabilities of the main udder health products manufacturers.
1 INTRODUCTION
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.2.1 INCLUSIONS & EXCLUSIONS
1.2.2 MARKET SCOPE
1.2.3 YEARS CONSIDERED
1.2.4 CURRENCY CONSIDERED
1.3 STAKEHOLDERS
1.4 RECESSION IMPACT
2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
2.2 RESEARCH METHODOLOGY DESIGN
2.2.1 SECONDARY DATA
2.2.1.1 Key data from secondary sources
2.2.2 PRIMARY DATA
2.2.2.1 Key data from primary sources
2.2.2.2 Key industry insights
2.3 MARKET SIZE ESTIMATION
2.4 MARKET BREAKDOWN AND DATA TRIANGULATION
2.5 MARKET SHARE ESTIMATION
2.6 STUDY ASSUMPTIONS
2.7 RESEARCH LIMITATIONS
2.7.1 METHODOLOGY-RELATED LIMITATIONS
2.7.2 SCOPE-RELATED LIMITATIONS
2.8 RISK ASSESSMENT
2.9 RECESSION IMPACT ANALYSIS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 UDDER HEALTH MARKET OVERVIEW
4.2 ASIA PACIFIC: UDDER HEALTH MARKET, BY PRODUCT AND COUNTRY (2023)
4.3 UDDER HEALTH MARKET: REGIONAL MIX
4.4 UDDER HEALTH MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
5.2.1 DRIVERS
5.2.1.1 Increasing demand for milk & dairy products
5.2.1.2 Rising incidence of mastitis
5.2.1.3 Increasing number of veterinary practitioners in developed markets and subsequent focus on preventive health measures
5.2.1.4 Technological advancements in udder health monitoring devices
5.2.2 RESTRAINTS
5.2.2.1 Limited resources and low awareness among small-scale dairy farmers
5.2.3 OPPORTUNITIES
5.2.3.1 Gradual transition from manual milking to mechanized milking solutions
5.2.3.2 Increasing per capita income of farmers in emerging markets
5.2.4 CHALLENGES
5.2.4.1 Stringent regulatory guidelines for livestock industry
5.3 INDUSTRY TRENDS
5.3.1 RISING DEMAND FOR ORGANIC UDDER HEALTH PRODUCTS
5.3.2 INCREASING R&D ACTIVITIES FOR INNOVATIVE UDDER HEALTH SOLUTIONS
5.3.3 EMPHASIS ON SUSTAINABLE PRACTICES
5.4 VALUE CHAIN ANALYSIS
5.5 TECHNOLOGY ANALYSIS
5.5.1 KEY TECHNOLOGIES
5.5.1.1 Telemedicine
5.5.1.2 AI integration in udder health
5.5.2 COMPLEMENTARY TECHNOLOGIES
5.5.2.1 Nutritional supplements
5.5.2.2 Integration of barn environmental management system
5.5.3 ADJACENT TECHNOLOGIES
5.5.3.1 Precision livestock farming
5.5.3.2 Integration of cattle & livestock management software
5.6 PORTER’S FIVE FORCES ANALYSIS
5.6.1 THREAT OF NEW ENTRANTS
5.6.2 BARGAINING POWER OF SUPPLIERS
5.6.3 BARGAINING POWER OF BUYERS
5.6.4 THREAT OF SUBSTITUTES
5.6.5 COMPETITIVE RIVALRY
5.7 REGULATORY LANDSCAPE
5.7.1 REGULATORY ANALYSIS
5.7.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
5.8 PATENT ANALYSIS
5.8.1 PATENT PUBLICATION TRENDS FOR UDDER HEALTH MARKET
5.8.2 INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS
5.9 TRADE ANALYSIS
5.9.1 TRADE ANALYSIS FOR UDDER HEALTH PRODUCTS
5.10 PRICING ANALYSIS
5.10.1 AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY TYPE
5.10.2 AVERAGE SELLING PRICE TREND OF UDDER HEALTH PRODUCTS, BY REGION
5.11 REIMBURSEMENT ANALYSIS
5.12 KEY CONFERENCES AND EVENTS (2024?2025)
5.13 KEY STAKEHOLDERS AND BUYING CRITERIA
5.13.1 KEY STAKEHOLDERS IN BUYING PROCESS
5.13.2 BUYING CRITERIA
5.14 UNMET NEEDS/END-USER EXPECTATIONS IN UDDER HEALTH MARKET
5.15 ECOSYSTEM ANALYSIS
5.16 CASE STUDY ANALYSIS
5.16.1 EARLY MASTITIS DETECTION WITH SENSOR TECHNOLOGY
5.16.2 AUTOMATION OF PRE-TEAT DIPPING FOR HIGH EFFICIENCY
5.16.3 UTILIZING HERD MANAGEMENT SOFTWARE FOR DATA-DRIVEN DECISIONS
5.17 SUPPLY CHAIN ANALYSIS
5.18 ADJACENT MARKETS
5.19 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
5.20 INVESTMENT & FUNDING SCENARIO
6 UDDER HEALTH MARKET, BY PRODUCT
6.1 INTRODUCTION
6.2 DEVICES
6.2.1 MILK QUALITY ANALYZERS
6.2.1.1 Ability to ensure quality & safety to drive market
6.2.2 MILK SAMPLING EQUIPMENT
6.2.2.1 Growing demand for automated sampling systems and manual sampling kits to drive market
6.2.3 MILK MANAGEMENT SYSTEMS
6.2.3.1 Rising technological advancements to support market growth
6.2.4 OTHER UDDER HEALTH DEVICES
6.3 PHARMACEUTICALS
6.3.1 ANTIBIOTICS
6.3.1.1 Advancements in formulations and delivery methods to propel market
6.3.2 VACCINES
6.3.2.1 Growth in dairy farm sector to boost demand
6.3.3 ANTI-INFLAMMATORY DRUGS
6.3.3.1 Innovative product launches to support market growth
6.3.4 INTRAMAMMARY INFUSIONS
6.3.4.1 Ability to provide targeted treatment during dry season to drive market
6.3.5 TEAT SEALANTS
6.3.5.1 Antimicrobial properties to drive market
6.3.6 OTHER UDDER HEALTH PHARMACEUTICALS
6.4 SUPPLEMENTS
6.4.1 VITAMINS & MINERALS
6.4.1.1 Essential requirement for optimal health of dairy cattle to fuel uptake
6.4.2 PROBIOTICS & PREBIOTICS
6.4.2.1 Growing demand for nutraceuticals to drive market
6.4.3 OTHER UDDER HEALTH SUPPLEMENTS
7 UDDER HEALTH MARKET, BY VETERINARY CARE SETTING
7.1 INTRODUCTION
7.2 DAIRY FARMS
7.2.1 GROWING DEMAND FOR MILK & DAIRY PRODUCTS TO DRIVE MARKET
7.3 VETERINARY HOSPITALS AND CLINICS
7.3.1 INCREASING ESTABLISHMENT OF CLINICAL PRACTICES ACROSS EMERGING ECONOMIES TO SUPPORT MARKET GROWTH
8 UDDER HEALTH MARKET, BY ANIMAL TYPE
8.1 INTRODUCTION
8.2 DAIRY CATTLE
8.2.1 GROWTH IN CATTLE POPULATION TO DRIVE MARKET
8.3 OTHER ANIMAL TYPES
9 UDDER HEALTH MARKET, BY DISEASE TYPE
9.1 INTRODUCTION
9.2 CLINICAL MASTITIS
9.2.1 INCREASING PREVALENCE AND HIGH COSTS ASSOCIATED WITH TREATMENT TO PROPEL MARKET
9.3 OTHER DISEASE TYPES
10 UDDER HEALTH MARKET, BY REGION
10.1 INTRODUCTION
10.2 NORTH AMERICA
10.2.1 NORTH AMERICA: RECESSION IMPACT
10.2.2 US
10.2.2.1 Increasing number of veterinary practitioners to drive market
10.2.3 CANADA
10.2.3.1 High R&D investments for udder monitoring products to drive market
10.3 EUROPE
10.3.1 EUROPE: RECESSION IMPACT
10.3.2 GERMANY
10.3.2.1 Advanced dairy farming practices to fuel uptake
10.3.3 UK
10.3.3.1 High adoption of advanced veterinary technologies to propel market
10.3.4 FRANCE
10.3.4.1 Expanding dairy industry to support market growth
10.3.5 ITALY
10.3.5.1 Growing investments in udder health solutions to drive market
10.3.6 SWITZERLAND
10.3.6.1 Growing demand for mastitis detectors to fuel uptake
10.3.7 SPAIN
10.3.7.1 Increasing establishment of dairy farms to boost demand
10.3.8 REST OF EUROPE
10.4 ASIA PACIFIC
10.4.1 ASIA PACIFIC: RECESSION IMPACT
10.4.2 JAPAN
10.4.2.1 Growing focus on automated milking systems to boost demand
10.4.3 CHINA
10.4.3.1 Increase in milk consumption to propel market
10.4.4 INDIA
10.4.4.1 Growing population of dairy cattle to drive market
10.4.5 AUSTRALIA
10.4.5.1 Stringent dairy farming regulations to propel market
10.4.6 SOUTH KOREA
10.4.6.1 Increasing awareness and adoption of preventive healthcare measures among dairy farmers to drive market
10.4.7 REST OF ASIA PACIFIC
10.5 LATIN AMERICA
10.5.1 LATIN AMERICA: RECESSION IMPACT
10.5.2 BRAZIL
10.5.2.1 Emphasis on improving milk quality to boost demand
10.5.3 MEXICO
10.5.3.1 Improvements in animal welfare standards to support market growth
10.5.4 REST OF LATIN AMERICA
10.6 MIDDLE EAST & AFRICA
10.6.1 MIDDLE EAST & AFRICA: RECESSION IMPACT
10.6.2 GCC COUNTRIES
10.6.2.1 Improvements in economic stability to support market growth
10.6.3 REST OF MIDDLE EAST & AFRICA
11 COMPETITIVE LANDSCAPE
11.1 OVERVIEW
11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
11.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN UDDER HEALTH MARKET
11.3 REVENUE ANALYSIS
11.4 MARKET SHARE ANALYSIS
11.4.1 RANKING OF KEY MARKET PLAYERS
11.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023
11.5.1 STARS
11.5.2 EMERGING LEADERS
11.5.3 PERVASIVE PLAYERS
11.5.4 PARTICIPANTS
11.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023
11.5.5.1 Company footprint
11.5.5.2 Region footprint
11.5.5.3 Product footprint
11.5.5.4 Veterinary care setting footprint
11.5.5.5 Animal type footprint
11.5.5.6 Disease type footprint
11.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023
11.6.1 PROGRESSIVE COMPANIES
11.6.2 RESPONSIVE COMPANIES
11.6.3 DYNAMIC COMPANIES
11.6.4 STARTING BLOCKS
11.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023
11.7 COMPANY VALUATION AND FINANCIAL METRICS
11.7.1 FINANCIAL METRICS
11.7.2 COMPANY VALUATION
11.8 R&D EXPENDITURE OF KEY PLAYERS
11.9 BRAND/PRODUCT COMPARISON
11.10 COMPETITIVE SCENARIO
11.10.1 PRODUCT LAUNCHES & APPROVALS
11.10.2 DEALS
11.10.3 EXPANSIONS
11.10.4 OTHER DEVELOPMENTS
12 COMPANY PROFILES
12.1 KEY PLAYERS
12.1.1 VETOQUINOL S.A.
12.1.1.1 Business overview
12.1.1.2 Products offered
12.1.1.3 Recent developments
12.1.1.3.1 Deals
12.1.1.3.2 Other developments
12.1.1.4 MnM view
12.1.1.4.1 Key strengths
12.1.1.4.2 Strategic choices
12.1.1.4.3 Weaknesses & competitive threats
12.1.2 ZOETIS INC.
12.1.2.1 Business overview
12.1.2.2 Products offered
12.1.2.3 Recent developments
12.1.2.3.1 Product launches
12.1.2.3.2 Expansions
12.1.2.4 MnM view
12.1.2.4.1 Key strengths
12.1.2.4.2 Strategic choices
12.1.2.4.3 Weaknesses & competitive threats
12.1.3 MERCK & CO., INC.
12.1.3.1 Business overview
12.1.3.2 Products offered
12.1.3.3 Recent developments
12.1.3.3.1 Product launches & approvals
12.1.3.4 MnM view
12.1.3.4.1 Key strengths
12.1.3.4.2 Strategic choices
12.1.3.4.3 Weaknesses & competitive threats
12.1.4 VIRBAC
12.1.4.1 Business overview
12.1.4.2 Products offered
12.1.4.3 MnM view
12.1.4.3.1 Key strengths
12.1.4.3.2 Strategic choices
12.1.4.3.3 Weaknesses & competitive threats
12.1.5 ECOLAB
12.1.5.1 Business overview
12.1.5.2 Products offered
12.1.5.3 Recent developments
12.1.5.3.1 Product launches
12.1.5.3.2 Deals
12.1.6 BOEHRINGER INGELHEIM INTERNATIONAL GMBH
12.1.6.1 Business overview
12.1.6.2 Products offered
12.1.6.3 MnM view
12.1.6.3.1 Key strengths
12.1.6.3.2 Strategic choices
12.1.6.3.3 Weaknesses & competitive threats
12.1.7 ELANCO ANIMAL HEALTH INCORPORATED
12.1.7.1 Business overview
12.1.7.2 Products offered
12.1.8 DELAVAL
12.1.8.1 Business overview
12.1.8.2 Products offered
12.1.8.3 Recent developments
12.1.8.3.1 Product launches
12.1.8.3.2 Other developments
12.1.9 ORFFA
12.1.9.1 Business overview
12.1.9.2 Products offered
12.1.9.3 Recent developments
12.1.9.3.1 Deals
12.1.10 AHV INTERNATIONAL B.V.
12.1.10.1 Business overview
12.1.10.2 Products offered
12.1.11 BOUMATIC LLC
12.1.11.1 Business overview
12.1.11.2 Products offered
12.1.12 GEA GROUP AKTIENGESELLSCHAFT
12.1.12.1 Business overview
12.1.12.2 Products offered
12.1.13 G SHEPHERD ANIMAL HEALTH
12.1.13.1 Business overview
12.1.13.2 Products offered
12.1.13.3 Recent developments
12.1.13.3.1 Other developments
12.1.14 CEVA SANTЙ ANIMALE
12.1.14.1 Business overview
12.1.14.2 Products offered
12.2 OTHER PLAYERS
12.2.1 ALBERT KERBL GMBH: COMPANY OVERVIEW
12.2.2 AMBIC EQUIPMENT LIMITED: COMPANY OVERVIEW
12.2.3 LELY: COMPANY OVERVIEW
12.2.4 ZENEX ANIMAL HEALTH INDIA PRIVATE LTD.: COMPANY OVERVIEW
12.2.5 DRAMINSKI S. A.: COMPANY OVERVIEW
12.2.6 RING BIOTECHNOLOGY CO LTD.: COMPANY OVERVIEW
12.2.7 NICOSIA BIOLABS INTERNATIONAL PRIVATE LIMITED: COMPANY OVERVIEW
12.2.8 BLACKMANGO HERBS: COMPANY OVERVIEW
12.2.9 KORU DIAGNOSTICS LTD.: COMPANY OVERVIEW
12.2.10 MASTAPLEX: COMPANY OVERVIEW
12.2.11 ARBROWN CO., JP LTD.: COMPANY OVERVIEW
13 APPENDIX
13.1 DISCUSSION GUIDE
13.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
13.3 CUSTOMIZATION OPTIONS
13.4 RELATED REPORTS
13.5 AUTHOR DETAILS
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.2.1 INCLUSIONS & EXCLUSIONS
1.2.2 MARKET SCOPE
1.2.3 YEARS CONSIDERED
1.2.4 CURRENCY CONSIDERED
1.3 STAKEHOLDERS
1.4 RECESSION IMPACT
2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
2.2 RESEARCH METHODOLOGY DESIGN
2.2.1 SECONDARY DATA
2.2.1.1 Key data from secondary sources
2.2.2 PRIMARY DATA
2.2.2.1 Key data from primary sources
2.2.2.2 Key industry insights
2.3 MARKET SIZE ESTIMATION
2.4 MARKET BREAKDOWN AND DATA TRIANGULATION
2.5 MARKET SHARE ESTIMATION
2.6 STUDY ASSUMPTIONS
2.7 RESEARCH LIMITATIONS
2.7.1 METHODOLOGY-RELATED LIMITATIONS
2.7.2 SCOPE-RELATED LIMITATIONS
2.8 RISK ASSESSMENT
2.9 RECESSION IMPACT ANALYSIS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 UDDER HEALTH MARKET OVERVIEW
4.2 ASIA PACIFIC: UDDER HEALTH MARKET, BY PRODUCT AND COUNTRY (2023)
4.3 UDDER HEALTH MARKET: REGIONAL MIX
4.4 UDDER HEALTH MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
5.2.1 DRIVERS
5.2.1.1 Increasing demand for milk & dairy products
5.2.1.2 Rising incidence of mastitis
5.2.1.3 Increasing number of veterinary practitioners in developed markets and subsequent focus on preventive health measures
5.2.1.4 Technological advancements in udder health monitoring devices
5.2.2 RESTRAINTS
5.2.2.1 Limited resources and low awareness among small-scale dairy farmers
5.2.3 OPPORTUNITIES
5.2.3.1 Gradual transition from manual milking to mechanized milking solutions
5.2.3.2 Increasing per capita income of farmers in emerging markets
5.2.4 CHALLENGES
5.2.4.1 Stringent regulatory guidelines for livestock industry
5.3 INDUSTRY TRENDS
5.3.1 RISING DEMAND FOR ORGANIC UDDER HEALTH PRODUCTS
5.3.2 INCREASING R&D ACTIVITIES FOR INNOVATIVE UDDER HEALTH SOLUTIONS
5.3.3 EMPHASIS ON SUSTAINABLE PRACTICES
5.4 VALUE CHAIN ANALYSIS
5.5 TECHNOLOGY ANALYSIS
5.5.1 KEY TECHNOLOGIES
5.5.1.1 Telemedicine
5.5.1.2 AI integration in udder health
5.5.2 COMPLEMENTARY TECHNOLOGIES
5.5.2.1 Nutritional supplements
5.5.2.2 Integration of barn environmental management system
5.5.3 ADJACENT TECHNOLOGIES
5.5.3.1 Precision livestock farming
5.5.3.2 Integration of cattle & livestock management software
5.6 PORTER’S FIVE FORCES ANALYSIS
5.6.1 THREAT OF NEW ENTRANTS
5.6.2 BARGAINING POWER OF SUPPLIERS
5.6.3 BARGAINING POWER OF BUYERS
5.6.4 THREAT OF SUBSTITUTES
5.6.5 COMPETITIVE RIVALRY
5.7 REGULATORY LANDSCAPE
5.7.1 REGULATORY ANALYSIS
5.7.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
5.8 PATENT ANALYSIS
5.8.1 PATENT PUBLICATION TRENDS FOR UDDER HEALTH MARKET
5.8.2 INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS
5.9 TRADE ANALYSIS
5.9.1 TRADE ANALYSIS FOR UDDER HEALTH PRODUCTS
5.10 PRICING ANALYSIS
5.10.1 AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY TYPE
5.10.2 AVERAGE SELLING PRICE TREND OF UDDER HEALTH PRODUCTS, BY REGION
5.11 REIMBURSEMENT ANALYSIS
5.12 KEY CONFERENCES AND EVENTS (2024?2025)
5.13 KEY STAKEHOLDERS AND BUYING CRITERIA
5.13.1 KEY STAKEHOLDERS IN BUYING PROCESS
5.13.2 BUYING CRITERIA
5.14 UNMET NEEDS/END-USER EXPECTATIONS IN UDDER HEALTH MARKET
5.15 ECOSYSTEM ANALYSIS
5.16 CASE STUDY ANALYSIS
5.16.1 EARLY MASTITIS DETECTION WITH SENSOR TECHNOLOGY
5.16.2 AUTOMATION OF PRE-TEAT DIPPING FOR HIGH EFFICIENCY
5.16.3 UTILIZING HERD MANAGEMENT SOFTWARE FOR DATA-DRIVEN DECISIONS
5.17 SUPPLY CHAIN ANALYSIS
5.18 ADJACENT MARKETS
5.19 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
5.20 INVESTMENT & FUNDING SCENARIO
6 UDDER HEALTH MARKET, BY PRODUCT
6.1 INTRODUCTION
6.2 DEVICES
6.2.1 MILK QUALITY ANALYZERS
6.2.1.1 Ability to ensure quality & safety to drive market
6.2.2 MILK SAMPLING EQUIPMENT
6.2.2.1 Growing demand for automated sampling systems and manual sampling kits to drive market
6.2.3 MILK MANAGEMENT SYSTEMS
6.2.3.1 Rising technological advancements to support market growth
6.2.4 OTHER UDDER HEALTH DEVICES
6.3 PHARMACEUTICALS
6.3.1 ANTIBIOTICS
6.3.1.1 Advancements in formulations and delivery methods to propel market
6.3.2 VACCINES
6.3.2.1 Growth in dairy farm sector to boost demand
6.3.3 ANTI-INFLAMMATORY DRUGS
6.3.3.1 Innovative product launches to support market growth
6.3.4 INTRAMAMMARY INFUSIONS
6.3.4.1 Ability to provide targeted treatment during dry season to drive market
6.3.5 TEAT SEALANTS
6.3.5.1 Antimicrobial properties to drive market
6.3.6 OTHER UDDER HEALTH PHARMACEUTICALS
6.4 SUPPLEMENTS
6.4.1 VITAMINS & MINERALS
6.4.1.1 Essential requirement for optimal health of dairy cattle to fuel uptake
6.4.2 PROBIOTICS & PREBIOTICS
6.4.2.1 Growing demand for nutraceuticals to drive market
6.4.3 OTHER UDDER HEALTH SUPPLEMENTS
7 UDDER HEALTH MARKET, BY VETERINARY CARE SETTING
7.1 INTRODUCTION
7.2 DAIRY FARMS
7.2.1 GROWING DEMAND FOR MILK & DAIRY PRODUCTS TO DRIVE MARKET
7.3 VETERINARY HOSPITALS AND CLINICS
7.3.1 INCREASING ESTABLISHMENT OF CLINICAL PRACTICES ACROSS EMERGING ECONOMIES TO SUPPORT MARKET GROWTH
8 UDDER HEALTH MARKET, BY ANIMAL TYPE
8.1 INTRODUCTION
8.2 DAIRY CATTLE
8.2.1 GROWTH IN CATTLE POPULATION TO DRIVE MARKET
8.3 OTHER ANIMAL TYPES
9 UDDER HEALTH MARKET, BY DISEASE TYPE
9.1 INTRODUCTION
9.2 CLINICAL MASTITIS
9.2.1 INCREASING PREVALENCE AND HIGH COSTS ASSOCIATED WITH TREATMENT TO PROPEL MARKET
9.3 OTHER DISEASE TYPES
10 UDDER HEALTH MARKET, BY REGION
10.1 INTRODUCTION
10.2 NORTH AMERICA
10.2.1 NORTH AMERICA: RECESSION IMPACT
10.2.2 US
10.2.2.1 Increasing number of veterinary practitioners to drive market
10.2.3 CANADA
10.2.3.1 High R&D investments for udder monitoring products to drive market
10.3 EUROPE
10.3.1 EUROPE: RECESSION IMPACT
10.3.2 GERMANY
10.3.2.1 Advanced dairy farming practices to fuel uptake
10.3.3 UK
10.3.3.1 High adoption of advanced veterinary technologies to propel market
10.3.4 FRANCE
10.3.4.1 Expanding dairy industry to support market growth
10.3.5 ITALY
10.3.5.1 Growing investments in udder health solutions to drive market
10.3.6 SWITZERLAND
10.3.6.1 Growing demand for mastitis detectors to fuel uptake
10.3.7 SPAIN
10.3.7.1 Increasing establishment of dairy farms to boost demand
10.3.8 REST OF EUROPE
10.4 ASIA PACIFIC
10.4.1 ASIA PACIFIC: RECESSION IMPACT
10.4.2 JAPAN
10.4.2.1 Growing focus on automated milking systems to boost demand
10.4.3 CHINA
10.4.3.1 Increase in milk consumption to propel market
10.4.4 INDIA
10.4.4.1 Growing population of dairy cattle to drive market
10.4.5 AUSTRALIA
10.4.5.1 Stringent dairy farming regulations to propel market
10.4.6 SOUTH KOREA
10.4.6.1 Increasing awareness and adoption of preventive healthcare measures among dairy farmers to drive market
10.4.7 REST OF ASIA PACIFIC
10.5 LATIN AMERICA
10.5.1 LATIN AMERICA: RECESSION IMPACT
10.5.2 BRAZIL
10.5.2.1 Emphasis on improving milk quality to boost demand
10.5.3 MEXICO
10.5.3.1 Improvements in animal welfare standards to support market growth
10.5.4 REST OF LATIN AMERICA
10.6 MIDDLE EAST & AFRICA
10.6.1 MIDDLE EAST & AFRICA: RECESSION IMPACT
10.6.2 GCC COUNTRIES
10.6.2.1 Improvements in economic stability to support market growth
10.6.3 REST OF MIDDLE EAST & AFRICA
11 COMPETITIVE LANDSCAPE
11.1 OVERVIEW
11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
11.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN UDDER HEALTH MARKET
11.3 REVENUE ANALYSIS
11.4 MARKET SHARE ANALYSIS
11.4.1 RANKING OF KEY MARKET PLAYERS
11.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023
11.5.1 STARS
11.5.2 EMERGING LEADERS
11.5.3 PERVASIVE PLAYERS
11.5.4 PARTICIPANTS
11.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023
11.5.5.1 Company footprint
11.5.5.2 Region footprint
11.5.5.3 Product footprint
11.5.5.4 Veterinary care setting footprint
11.5.5.5 Animal type footprint
11.5.5.6 Disease type footprint
11.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023
11.6.1 PROGRESSIVE COMPANIES
11.6.2 RESPONSIVE COMPANIES
11.6.3 DYNAMIC COMPANIES
11.6.4 STARTING BLOCKS
11.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023
11.7 COMPANY VALUATION AND FINANCIAL METRICS
11.7.1 FINANCIAL METRICS
11.7.2 COMPANY VALUATION
11.8 R&D EXPENDITURE OF KEY PLAYERS
11.9 BRAND/PRODUCT COMPARISON
11.10 COMPETITIVE SCENARIO
11.10.1 PRODUCT LAUNCHES & APPROVALS
11.10.2 DEALS
11.10.3 EXPANSIONS
11.10.4 OTHER DEVELOPMENTS
12 COMPANY PROFILES
12.1 KEY PLAYERS
12.1.1 VETOQUINOL S.A.
12.1.1.1 Business overview
12.1.1.2 Products offered
12.1.1.3 Recent developments
12.1.1.3.1 Deals
12.1.1.3.2 Other developments
12.1.1.4 MnM view
12.1.1.4.1 Key strengths
12.1.1.4.2 Strategic choices
12.1.1.4.3 Weaknesses & competitive threats
12.1.2 ZOETIS INC.
12.1.2.1 Business overview
12.1.2.2 Products offered
12.1.2.3 Recent developments
12.1.2.3.1 Product launches
12.1.2.3.2 Expansions
12.1.2.4 MnM view
12.1.2.4.1 Key strengths
12.1.2.4.2 Strategic choices
12.1.2.4.3 Weaknesses & competitive threats
12.1.3 MERCK & CO., INC.
12.1.3.1 Business overview
12.1.3.2 Products offered
12.1.3.3 Recent developments
12.1.3.3.1 Product launches & approvals
12.1.3.4 MnM view
12.1.3.4.1 Key strengths
12.1.3.4.2 Strategic choices
12.1.3.4.3 Weaknesses & competitive threats
12.1.4 VIRBAC
12.1.4.1 Business overview
12.1.4.2 Products offered
12.1.4.3 MnM view
12.1.4.3.1 Key strengths
12.1.4.3.2 Strategic choices
12.1.4.3.3 Weaknesses & competitive threats
12.1.5 ECOLAB
12.1.5.1 Business overview
12.1.5.2 Products offered
12.1.5.3 Recent developments
12.1.5.3.1 Product launches
12.1.5.3.2 Deals
12.1.6 BOEHRINGER INGELHEIM INTERNATIONAL GMBH
12.1.6.1 Business overview
12.1.6.2 Products offered
12.1.6.3 MnM view
12.1.6.3.1 Key strengths
12.1.6.3.2 Strategic choices
12.1.6.3.3 Weaknesses & competitive threats
12.1.7 ELANCO ANIMAL HEALTH INCORPORATED
12.1.7.1 Business overview
12.1.7.2 Products offered
12.1.8 DELAVAL
12.1.8.1 Business overview
12.1.8.2 Products offered
12.1.8.3 Recent developments
12.1.8.3.1 Product launches
12.1.8.3.2 Other developments
12.1.9 ORFFA
12.1.9.1 Business overview
12.1.9.2 Products offered
12.1.9.3 Recent developments
12.1.9.3.1 Deals
12.1.10 AHV INTERNATIONAL B.V.
12.1.10.1 Business overview
12.1.10.2 Products offered
12.1.11 BOUMATIC LLC
12.1.11.1 Business overview
12.1.11.2 Products offered
12.1.12 GEA GROUP AKTIENGESELLSCHAFT
12.1.12.1 Business overview
12.1.12.2 Products offered
12.1.13 G SHEPHERD ANIMAL HEALTH
12.1.13.1 Business overview
12.1.13.2 Products offered
12.1.13.3 Recent developments
12.1.13.3.1 Other developments
12.1.14 CEVA SANTЙ ANIMALE
12.1.14.1 Business overview
12.1.14.2 Products offered
12.2 OTHER PLAYERS
12.2.1 ALBERT KERBL GMBH: COMPANY OVERVIEW
12.2.2 AMBIC EQUIPMENT LIMITED: COMPANY OVERVIEW
12.2.3 LELY: COMPANY OVERVIEW
12.2.4 ZENEX ANIMAL HEALTH INDIA PRIVATE LTD.: COMPANY OVERVIEW
12.2.5 DRAMINSKI S. A.: COMPANY OVERVIEW
12.2.6 RING BIOTECHNOLOGY CO LTD.: COMPANY OVERVIEW
12.2.7 NICOSIA BIOLABS INTERNATIONAL PRIVATE LIMITED: COMPANY OVERVIEW
12.2.8 BLACKMANGO HERBS: COMPANY OVERVIEW
12.2.9 KORU DIAGNOSTICS LTD.: COMPANY OVERVIEW
12.2.10 MASTAPLEX: COMPANY OVERVIEW
12.2.11 ARBROWN CO., JP LTD.: COMPANY OVERVIEW
13 APPENDIX
13.1 DISCUSSION GUIDE
13.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
13.3 CUSTOMIZATION OPTIONS
13.4 RELATED REPORTS
13.5 AUTHOR DETAILS
